Skip to main content
. 2023 Jul 26;18:124. doi: 10.1186/s13014-023-02319-z

Table 2.

Global and regional T1, ECV, T2, and IBS values

Global Basal Mid Apical p
T1 (ms) median (Q1-Q3) 1235 (1199–1273) 1220 (1193–1262) 1219 (1179–1268) 1252 (1168–1319) 0.393 1
*% abnormal 90.00 53.33 50.00 66.67 0.5292
ECV (%) median (Q1-Q3) 28.05 (26.11–30.23) 27.40 (25.23–28.78) 26.69 (24.87–29.29) 28.98 (26.65–32.51) 0.008 1
*% abnormal 80.00 46.67 43.33 60.00 0.038 2
T2 (ms) median (Q1-Q3) 35.54 (34.61–38.23) 35.82 (34.29–37.39) 34.88 (34.03–36.97) 36.85 (34.40–41.03) 0.010 1
*% abnormal 6.90 3.45 0.00 3.45 0.3682
IBS (dB) mean (SD) 1.04 (2.80) 1.99 (3.93) 1.06 (3.73) -0.79 (4.16) 0.0801
*% abnormal 76.67 46.15 61.54 32.14 0.3682

One patient’s T2 values were missing, and two to four patients’ global or regional IBS values were missing and could not be evaluated. ECV, extracellular volume; IBS, integrated backscatter change from baseline to 6-year follow-up; *% abnormal, percentage of patients with abnormally high segmental values in a respective region; dB, decibel; p, p-value from 1Friedmans test or 2Cochran’s Q test for the difference between the basal, mid, and apical regions.